1). Bae JH, Seung KB, Jung HO, et al. Analysis of Korean carotid intima-media thickness in Korean healthy subjects and patients with risk factors: Korea multicenter epidemiological study. Korean Circ J. 2005; 35:513–24.
Article
2). O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Stroke. 1996; 27:224–31.
3). Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general popular of a Japanese city: the Suita study. Stroke. 1997; 28:518–25.
4). Jeong IB, Kim KY, Bae JH, et al. The carotid intima-media thickness as a screening test for coronary artery disease. Korean Circ J. 2005; 35:460–6.
Article
5). Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities(ARIC) study. Stroke. 1995; 26:386–91.
6). Crouse JR, Goldbourt U, Evans G, et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities(ARIC) cohort. Stroke. 1996; 27:69–75.
7). Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol. 1996; 16:984–91.
Article
8). Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation. 2001; 104:2815–9.
9). Park KR, Kim KY, Yoon SM, Bae JH, Seong IW. Correlation between intima-media thickness in carotid artery and the extent of coronary atherosclerosis. Korean Circ J. 2003; 33:401–8.
Article
10). Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med. 1994; 236:567–73.
Article
11). Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 1997; 28:1189–94.
Article
12). Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986; 74:1399–406.
Article
13). O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999; 340:14–22.
14). Kieltyka L, Urbina EM, Tang R, Bond MG, Srinivasan SR, Berenson GS. Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study. Atherosclerosis. 2003; 170:125–30.
Article
15). Barth JD. Which tools are in your cardiac workshop?: carotid ultrasound, endothelial function, and magnetic resonance imaging. Am J Cardiol. 2001; 87:8A–14A.
Article
16). Hodis HN, Mack WJ, LaBree L, et al. The role of carotid intima-media thickness in predicting clinical coronary event. Ann Intern Med. 1998; 128:262–9.
17). Crouse JR 3rd, Byington RP, Bond MG, et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries(PLAC-II). Am J Cardiol. 1995; 75:455–9.
18). Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. Ann Intern Med. 1996; 124:548–56.
Article
19). McMahon S, Sharpe N, Gamble G, et al. Effects of lowering average or below average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. Circulation. 1998; 97:1784–90.
20). Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Ver-nalis MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized clinical trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002; 106:2055–60.
21). Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol(ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation. 2004; 110:3512–7.
22). Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation. 2000; 102:1503–10.
Article
23). Rajagopal V, Rockson S. Coronary restenosis: a review of mechanisms and management. Am J Med. 2003; 115:547–53.
Article
24). Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol. 1999; 34:1512–21.
Article
25). Hojo Y, Ikeda U, Katsuki T, et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart. 2000; 84:83–7.
Article
26). Amar J, Fauvel J, Drouet L, et al. Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1. J Hypertens. 2006; 24:1083–8.
Article
27). Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis. Stroke. 2006; 37:351–7.
28). Elkind MS, Rundek T, Sciacca RR, et al. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis. 2005; 180:181–7.
Article